Antibody Subclass and Glycosylation Shift Following Effective TB Treatment

Antibody Subclass and Glycosylation Shift Following Effective TB Treatment

Show other versions (1)

<jats:p>With an estimated 25% of the global population infected with <jats:italic>Mycobacterium tuberculosis</jats:italic> (<jats:italic>Mtb</jats:italic>), tuberculosis (TB) remains a leading cause of death by infectious diseases. Humoral immunity following TB treatmen...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Grace, Patricia S, Dolatshahi, Sepideh, Lu, Lenette L, Cain, Adam, Palmieri, Fabrizio, Petrone, Linda, Fortune, Sarah M, Ottenhoff, Tom HM, Lauffenburger, Douglas A, Goletti, Delia, Joosten, Simone A, Alter, Galit
פורמט: Article
שפה:English
יצא לאור: Frontiers Media SA 2021
גישה מקוונת:https://hdl.handle.net/1721.1/136134

אינטרנט

https://hdl.handle.net/1721.1/136134

פריטים דומים